BACKGROUND & AIMS: Studies have reported higher rates of advanced colorectal neoplasia in men than in women. We performed a meta-analysis to provide a quantitative pooled risk estimate of the association between gender and advanced colorectal neoplasia. METHODS: We conducted a systematic review to identify studies of average risk and asymptomatic individuals undergoing screening colonoscopy. We also included studies of subjects with a family history of colorectal neoplasia. We used random effects models to evaluate pooled relative risk estimates and performed heterogeneity and publication bias analyses. The primary outcome measure was relative risk of advanced neoplasia in men compared with women. A secondary outcome measure was relative risk for colorectal cancer. RESULTS: Seventeen studies consisting of 18 different populations were included, comprising 924,932 men and women. The pooled relative risk estimate for advanced neoplasia for men compared with women was 1.83 (95% confidence interval [CI], 1.69 -1.97). This positive association between gender and advanced neoplasia was significant across all age groups from 40 to older than 70 years. In 5 studies, the relative risk estimate for cancer for men compared with women was 2.02 (95% CI, 1.53-2.66). Significant heterogeneity was found for the overall analysis and for studies reporting on cancer but not for studies thate xcluded subjects with a family history or for those analyses grouped by age. CONCLUSIONS: This meta-analysis provides strong evidence that men are at greater risk for advanced colorectal neoplasia across all age groups. This might inform decisions to create sex-specific colorectal cancer screening recommendations.
BACKGROUND & AIMS: Studies have reported higher rates of advanced colorectal neoplasia in men than in women. We performed a meta-analysis to provide a quantitative pooled risk estimate of the association between gender and advanced colorectal neoplasia. METHODS: We conducted a systematic review to identify studies of average risk and asymptomatic individuals undergoing screening colonoscopy. We also included studies of subjects with a family history of colorectal neoplasia. We used random effects models to evaluate pooled relative risk estimates and performed heterogeneity and publication bias analyses. The primary outcome measure was relative risk of advanced neoplasia in men compared with women. A secondary outcome measure was relative risk for colorectal cancer. RESULTS: Seventeen studies consisting of 18 different populations were included, comprising 924,932 men and women. The pooled relative risk estimate for advanced neoplasia for men compared with women was 1.83 (95% confidence interval [CI], 1.69 -1.97). This positive association between gender and advanced neoplasia was significant across all age groups from 40 to older than 70 years. In 5 studies, the relative risk estimate for cancer for men compared with women was 2.02 (95% CI, 1.53-2.66). Significant heterogeneity was found for the overall analysis and for studies reporting on cancer but not for studies thate xcluded subjects with a family history or for those analyses grouped by age. CONCLUSIONS: This meta-analysis provides strong evidence that men are at greater risk for advanced colorectal neoplasia across all age groups. This might inform decisions to create sex-specific colorectal cancer screening recommendations.
Authors: Joseph C Anderson; Koorosh Moezardalan; Catherine R Messina; Michael Latreille; Robert D Shaw Journal: Dig Dis Sci Date: 2011-07-13 Impact factor: 3.199
Authors: Elizabeth D Kantor; Carolyn M Hutter; Jessica Minnier; Sonja I Berndt; Hermann Brenner; Bette J Caan; Peter T Campbell; Christopher S Carlson; Graham Casey; Andrew T Chan; Jenny Chang-Claude; Stephen J Chanock; Michelle Cotterchio; Mengmeng Du; David Duggan; Charles S Fuchs; Edward L Giovannucci; Jian Gong; Tabitha A Harrison; Richard B Hayes; Brian E Henderson; Michael Hoffmeister; John L Hopper; Mark A Jenkins; Shuo Jiao; Laurence N Kolonel; Loic Le Marchand; Mathieu Lemire; Jing Ma; Polly A Newcomb; Heather M Ochs-Balcom; Bethann M Pflugeisen; John D Potter; Anja Rudolph; Robert E Schoen; Daniela Seminara; Martha L Slattery; Deanna L Stelling; Fridtjof Thomas; Mark Thornquist; Cornelia M Ulrich; Greg S Warnick; Brent W Zanke; Ulrike Peters; Li Hsu; Emily White Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-07-03 Impact factor: 4.254